The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 332:962 April 6, 1995 Number 14
NextNext

Photopheresis for Chronic Rejection of Lung Allografts

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Extracorporeal photochemotherapy, or photopheresis, is a technique for modulating cell-mediated immunity that was first described as a successful treatment for cutaneous T-cell lymphoma.1 In 1992, Costanzo-Nordin et al. reported the success of photopheresis as an experimental therapy in eight of nine episodes of acute rejection after heart transplantation.2 Our experience is similar, with five of six episodes resolving with photopheresis (unpublished data). We describe three patients with bronchiolitis obliterans and chronic rejection after single-lung transplantation whose pulmonary function stabilized following the initiation of photopheresis.

A 21-year-old woman received a lung transplant for pulmonary hypertension resulting from a . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.